Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pituitary Neoplasms 1Pituitary ACTH Hypersecretion 1Lymphoma, Follicular 1Hemophilia A 1Gastrointestinal Hemorrhage 1Colorectal Neoplasms 1Castrate Resistance Prostate Cancer 1Breast Neoplasms 1

Interventions

sodium phosphate 1prucalopride 1picosulfate sodium 1isatuximab 1Single-Balloon Enteroscopy 1Radiotherapy 1Rabeprazole 1Polyethylene Glycols 1Physical Examination 1Gastroscopy 1Endoscopy, Digestive System 1Diatrizoate Meglumine 1Deamino Arginine Vasopressin 1Colonoscopy 1Blood Coagulation Tests 1Aspirin 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Hemorrhage × Deamino Arginine Vasopressin × Clear all
NCT01623206 2017-08-24

Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding

Laboratorio Elea Phoenix S.A.

Phase 2 Completed
30 enrolled
Gastrointestinal

Gastrointestinal Hemorrhage, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡